Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri)

Pakistan Journal of Medical Sciences

Volumn 30, Issue 4, 2014, Pages

  Tosun, Ayse Kavasoglu ^a   Tosun, Ismet ^b   Suer, Necdet ^a  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b Umraniye Education and Research Hospital Otolaryngology Clinic Umraniye   (Turkey)

Author keywords

Anemia; Heavy Menstrual Bleeding (HMB); Leiomyoma; LNG IUD; Oral progesterone

Indexed keywords

HEMOGLOBIN; LEVONORGESTREL; NORETHISTERONE ACETATE;

ARTICLE; BLEEDING DISORDER; BODY WEIGHT DISORDER; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MASTALGIA; MENORRHAGIA; OPEN STUDY; ORAL CONTRACEPTION; PARALLEL DESIGN; PATIENT COMPLIANCE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE; TUMOR VOLUME; UTERUS MYOMA; VISUAL BLEEDING SCORE; WEIGHT GAIN;

EID: 84901981685     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.304.4219     Document Type: Article

References (17)

1. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol. 1990;97(4):285-298. doi:10.1111/j.1471-0528.1990.tb01804.x
2. Brosens I, Deprest J, Dal Cin P & Van den BH. Clinical significance of cytogenetic abnormalities in uterin myomas. Fertil Steril. 1998;69(2):232-235. doi:10.1016/s0015-0282(97)00472-x
3. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstetrics& Gynecology. 2002;99:229-234. doi:10.1016/s0029-7844(01)01723-9.
4. Nagrani R, Bowen-Simpkins P, Barrington JW. Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia? BJOG. 2002;109(3):345-347. doi:10.1111/j.1471-0528.2002.01274.x.
5. Singer A, Ikomi A. Successful treatment of uterine fibroids using an intrauterine progesterone device. Int J Gynecol Obstet. 1994;46:55.
6. Higham JM, O'Brien PM, Shaw RW. Assesment of menstruel blood loss using a pictorial chart. BR J Obstet Gynaecol 1990;97:734-739.
7. Market and Research International (MORI) Women's health in 1990. Market Opinion and Research International, 1990 (research study conducted on behalf of Parke-Davis Laboratories).
8. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: A systematic review and meta-analysis. Obstet Gynecol. 2009;18:1104-1116. doi:10.1097/aog.0b013e3181a1d3ce
9. Wildemeersch D & Schacht E. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2002;102(1):74-79. doi:10.1016/ s0301-2115(01)00555-3.
10. Monteiro I, Bahamondes L, Diaz J, Perrotti M, Petta C. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: A pilot study(1). Contraception. May 2002;65(5):325-328. doi:10.1016/s0010-7824(02)00283-4
11. Gunes M, Ozdegirmenci O, Kayikcioglu F, Haberal A., Kaplan M. The effect of levonorgestrel Intrauterine System on Uterine Myomas: A1-Year Follow-up Study. J Minim Invasive Gynecol. 2008;15(6):735-738.
12. Backman T, Benefit-Risk assesment of the levonorgestrel system in contraception. Drug Saf. 2004;271(15):1185-1204. doi:10.2165/00002018-200427150-00003.
13. Maruo T, Matsuo H, Samoto T. Shimomura Y, Ku-rachi O, Gao Z, Wang Y, Spitz IM, Johansson E. Effects of progestrone on uterine leiomyoma growth and apoptosis. Steoid. 2000;65:585-592. doi:10.1016/s0039-128x(00)00171-9.
14. Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril. 2003;79(5):1194-1198. doi:10.1016/s0015-0282(03)00175-4.
15. Magalhaes J, Aldrighi JM, Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel releasing intrauterine device with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception. 2007;75(3):193-198. doi:10.1016/j.contraception.2006.11.004.
16. Ware RS, Inki P. The levonorgestrel intrauterine system. Long-term contraception and therapeutic effects. Future Medicine. 2005;1(2):171-182. doi:10.2217/17455057.1.2.171.
17. Boon J, Scholten PC, Oldenhave A, Heintz AP. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. Maturitas. 2003;46(1):69-77. doi:10.1016/s0378-5122(03)00163-4.